Does Increasing Attentional Control Decrease Acute Fear Response
NCT04080115 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 201
Last updated 2024-07-19
Summary
Despite decades of research, current psychological treatments designed to treat a variety of mental illnesses are not effective for all who receive them. Specifically, well-supported treatments for mental illnesses that involve fear (e.g., PTSD, panic) appear to be effective for the majority of individuals, but consistently leave a group of "treatment non-responders." One potential explanation for the observed discrepancy in treatment response may be the focus of modern psychotherapies on relieving symptoms specific to categorical diagnoses, rather than mechanisms underlying why the individual is experiencing the symptoms. Recently, fear-based psychological disorders (e.g., PTSD, specific phobia, panic disorder, social anxiety) have been identified as sharing a distinct set of biomarkers, including genetic biomarkers of acute fear (i.e., fear in the moment) and impairments in controlling attention. Neurobehavioral interventions are therefore a promising class of treatments designed to target the biological markers that may be maintaining the symptoms of various psychological disorders. The Attention Training Technique (ATT) is a neurobehavioral intervention that has garnered attention through its demonstrated effectiveness in reducing symptoms across a variety of psychological diagnoses. While grounded in well-established theory, the mechanisms of change in ATT are largely unknown. One proposed mechanism may be that ATT promotes functional connectivity between regions in the brain implicated in top-down executive control over attention (ventromedial prefrontal cortex \[vmPFC\] and dorsolateral prefrontal cortex \[dlPFC\]) and bottom-up attention networks (dorsal anterior cingulate cortex \[dACC\] and amygdala), resulting in increased top-down regulation of potentially problematic bottom-up attentional processes. The same brain regions implicated in both top-down and bottom-up attentional processes have also been associated with fear responding (i.e., startle response) and fear learning (i.e., how quickly one learns that a stimuli is safe or to be feared). Taken together, the research suggests that acute fear responding may be decreased through increased executive control over attention through engagement in ATT. The proposed randomized clinical trial will test whether a self-administered brief neurobehavioral intervention (ATT) to increase attentional control will decrease acute fear responding, and whether this change is associated with increased ability to handle attentional interference, an ability associated with normative dACC functioning and measured by behavioral proxy in this study via the Multi-Source Interference Task (MSIT). It is expected that those who engage in ATT will show greater attentional control efficiency, which will decrease their acute fear response. It is also expected that those who engage in ATT will also show lower sensitivity to attentional interference (measured through the MSIT) and will exhibit decreases in their reported fear as their attentional control increases over the course of the intervention. Additionally, it is expected that the intervention (ATT) will indirectly decrease symptoms of categorical fear-based psychological diagnoses through the identified biomarkers (i.e., attentional control, attentional interference sensitivity, acute fear response) to decrease reported symptoms.
Conditions
- Fear
- Attention
Interventions
- BEHAVIORAL
-
Attention Training Technique
ATT will be administered through a customized Expiwell smartphone application that will be downloaded onto participants' cell phones at the first laboratory session (T2). For the purposes of the proposed study, participants need to complete the intervention once a day, for the six days between their lab sessions; signals will begin the day after their T2 session and they will be notified up to a maximum of five times per day to complete their daily session. The ATT sessions are comprised of three phases. The first is a 5-minute phase during which the participant is instructed to attend to specific sounds in the recording and disregard other sounds. The subsequent 5-minute phase includes instructions to rapidly switch their attention between sounds in the recording. The final phase is a dual attention task lasting 2 minutes wherein the participant is instructed to pay attention to multiple sounds in the recording at once. In total, each session of ATT lasts 12 minutes.
- BEHAVIORAL
-
Sham intervention control condition
The sham control condition consists of the same 12 minutes of simultaneous sounds as the ATT technique, but will not include any verbal instruction, thus isolating the effects of intentional orientation of attention.
Sponsors & Collaborators
-
Northern Illinois University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-05
- Primary Completion
- 2024-04-30
- Completion
- 2024-04-30
Countries
- United States
Study Locations
More Related Trials
-
Optimizing Exposure Therapy for Anxiety Disorders
NCT04048824 ·Status: COMPLETED ·Phase: NA
-
Mechanisms of Panic Disorders Treatment
NCT01323556 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effects of Verbal Instructions on Fear Extinction and Extinction Retrieval
NCT05718271 ·Status: COMPLETED ·Phase: NA
-
Internet-delivered Attention Training for Obsessive-Compulsive Disorder
NCT02018848 ·Status: COMPLETED ·Phase: NA
-
A Placebo-Controlled Trial of D-Cycloserine and Exposure Therapy for Combat-PTSD
NCT00371176 ·Status: COMPLETED ·Phase: NA
-
Brief Group Psychotherapy for Anxiety and Depression
NCT04489641 ·Status: COMPLETED ·Phase: NA
-
Augmentation of Exposure Using Positive Mental Rehearsal in Individuals With Increased Social Anxiety
NCT06564402 ·Status: RECRUITING ·Phase: NA
-
A Clinical Research Studying a Method of Intervention for Children Diagnosed With Anxiety Disorder: Attentional Bias Intervention
NCT00482820 ·Status: COMPLETED ·Phase: NA
-
Transcranial Direct Current Stimulation and Extinction in Obsessive Compulsive Disorder
NCT06834217 ·Status: RECRUITING ·Phase: NA
-
Internet-based Exposure Therapy for Excessive Worry
NCT02331537 ·Status: COMPLETED ·Phase: NA
-
Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans
NCT05120635 ·Status: RECRUITING ·Phase: NA
-
Neuroimaging of Pavlovian Fear Conditioning Processes in Patients With Pathological Anxiety
NCT03498599 ·Status: UNKNOWN ·Phase: NA
-
Interactive Computer Treatment for Panic Disorder
NCT00063375 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Psychotherapy Programs to Treat Panic Disorder
NCT00353470 ·Status: COMPLETED ·Phase: PHASE3
-
Test of an Inhibitory Learning Model of Extinction in Treatment of Anxious Youth
NCT03372915 ·Status: COMPLETED ·Phase: NA
-
Longterm Outcome of Inpatient Cognitive and Behavioral Therapies for Agoraphobia
NCT01446172 ·Status: COMPLETED
-
Effectiveness of Intensive Cognitive Behavioral Therapy in Treating Adolescent Panic Disorder and Agoraphobia
NCT00576719 ·Status: COMPLETED ·Phase: PHASE2
-
Psychodynamic Therapy for Treating Panic Disorder
NCT00128388 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Threat-Avoidance Learning in Anxiety Patients
NCT02336802 ·Status: UNKNOWN
-
Attention Bias Modification Treatment (ABMT) for Anxiety Disorders in Youth
NCT02460536 ·Status: COMPLETED ·Phase: NA
-
The Modular Protocol for Mental Health (MPMH)
NCT03143634 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Neurobiology of Generalized Fear-Conditioning & Avoidance in Anxiety Disorders
NCT03033056 ·Status: COMPLETED
-
Attention Disengagement Training for Social Phobia
NCT00684320 ·Status: COMPLETED ·Phase: NA
-
Neurotherapeutics as an Adjunctive Approach to Enhance Exposure Outcomes in Anxiety
NCT04953832 ·Status: COMPLETED ·Phase: NA
-
Cognitive Behavior Therapy vs Exposure in Vivo in the Treatment of Panic Disorder With Agoraphobia
NCT01680237 ·Status: TERMINATED ·Phase: NA